Todd C. Davis, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 15,000 shares at $10.90 ($164K) on 2011-08-10, disclosed to the SEC on 2011-08-11.
Open-market purchase of $164k LGND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| LGND | BUY | 2024-08-09 | $243K | — | Filing → |
| LGND | BUY | 2023-09-25 | $238K | — | Filing → |
| LGND | SELL | 2021-02-12 | $2.2M | — | Filing → |